RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.6B
This Quarter Return
+50.37%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$3.65B
AUM Growth
+$3.65B
(+51%)
Cap. Flow
+$447M
Cap. Flow
% of AUM
12.25%
Top 10 Holdings %
Top 10 Hldgs %
23.51%
Holding
147
New
14
Increased
83
Reduced
11
Closed
4
Top Buys
| 1 |
Novavax
NVAX
|
$47.6M |
| 2 |
Centene
CNC
|
$35.9M |
| 3 |
UnitedHealth
UNH
|
$31M |
| 4 |
Edwards Lifesciences
EW
|
$26.8M |
| 5 |
Royalty Pharma
RPRX
|
$24.3M |
Top Sells
| 1 |
FTSV
Forty Seven, Inc. Common Stock
FTSV
|
$42.7M |
| 2 |
Intuitive Surgical
ISRG
|
$18.5M |
| 3 |
Ultragenyx Pharmaceutical
RARE
|
$7.9M |
| 4 |
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
|
$7.48M |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
$5.41M |
Sector Composition
| 1 | Healthcare | 92.16% |
| 2 | Consumer Staples | 1.09% |
| 3 | Consumer Discretionary | 0.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Prothena Corp
PRTA
$441M
| $10.3M | 0.28% | 989,218 +489,218 | +98% | +$5.12M |
|
102
Enliven Therapeutics
ELVN
$1.2B
| $10.1M | 0.28% | 364,733 -81,203 | -18% | -$2.24M |
|
|
SWAV
103
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $9.36M | 0.26% | +197,500 | New | +$9.36M |
|
|
GMDA
104
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
| $9.22M | 0.25% | 2,016,656 +1,016,656 | +102% | +$4.65M |
|
105
Legend Biotech
LEGN
$6.41B
| $8.76M | 0.24% | +205,896 | New | +$8.76M |
|
|
PRTK
106
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $8.64M | 0.24% | 1,655,164 +128,854 | +8% | +$673K |
|
107
Repare Therapeutics
RPTX
$71.7M
| $8.53M | 0.23% | +274,815 | New | +$8.53M |
|
|
OBSV
108
DELISTED
ObsEva SA Ordinary Shares
OBSV
| $8.39M | 0.23% | 1,423,552 +23,552 | +2% | +$139K |
|
109
Spero Therapeutics
SPRO
$116M
| $8.32M | 0.23% | 615,177 +10,177 | +2% | +$138K |
|
110
OneSpaWorld
OSW
$2.32B
| $8.3M | 0.23% | 1,740,000 +690,000 | +66% | +$3.29M |
|
111
STAAR Surgical
STAA
$1.36B
| $8M | 0.22% | 130,000 -25,000 | -16% | -$1.54M |
|
|
CHMA
112
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $7.49M | 0.21% | 1,392,312 +42,312 | +3% | +$228K |
|
|
BLU
113
DELISTED
BELLUS Health Inc.
BLU
| $7.16M | 0.2% | +696,115 | New | +$7.16M |
|
|
NGM
114
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $7.06M | 0.19% | 357,409 +6,309 | +2% | +$125K |
|
|
IGMS
115
DELISTED
IGM Biosciences
IGMS
| $6.96M | 0.19% | +95,278 | New | +$6.96M |
|
116
AnaptysBio
ANAB
$569M
| $6.85M | 0.19% | 306,713 +6,713 | +2% | +$150K |
|
117
10x Genomics
TXG
$1.74B
| $6.79M | 0.19% | 76,000 | – | – |
|
|
XENT
118
DELISTED
Intersect ENT, Inc
XENT
| $6.77M | 0.19% | 500,000 | – | – |
|
119
MacroGenics
MGNX
$112M
| $6.55M | 0.18% | 234,516 +4,516 | +2% | +$126K |
|
120
Xenon Pharmaceuticals
XENE
$2.98B
| $6.47M | 0.18% | 515,711 +15,711 | +3% | +$197K |
|
|
TRIL
121
DELISTED
Trillium Therapeutics Inc.
TRIL
| $6.17M | 0.17% | 762,618 +12,618 | +2% | +$102K |
|
122
Akero Therapeutics
AKRO
$3.74B
| $6.06M | 0.17% | 242,985 +17,985 | +8% | +$448K |
|
123
Passage Bio
PASG
$22.7M
| $5.56M | 0.15% | 203,436 -21,564 | -10% | -$589K |
|
|
BNR
124
Burning Rock Biotech
BNR
$93.6M
| $5.4M | 0.15% | +200,000 | New | +$5.4M |
|
125
Q32 Bio
QTTB
$20.9M
| $5.34M | 0.15% | 351,638 -73,362 | -17% | -$1.11M |
|